Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Astrocytoma, Grade IV

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Astrocytoma, Grade IV in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahé, C1
Bernhard, M1
Bobirnac, I1
Keser, C1
Loetscher, E1
Feuerbach, D1
Dev, KK1
Schoeffter, P1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Astrocytoma, Grade IV

ArticleYear
Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines.
    British journal of pharmacology, 2004, Volume: 143, Issue:3

    Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blotting, Western; Cell Line,

2004